search
Back to results

Reducing INfection at the Surgical SitE With Antibiotic Irrigation During Ventral Hernia Repair (RINSE Trial) (RINSE)

Primary Purpose

Ventral Hernia Repair

Status
Completed
Phase
Phase 3
Locations
United States
Study Type
Interventional
Intervention
Gemcitabine/ clindamycin
Normal saline
Sponsored by
Prisma Health-Upstate
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Ventral Hernia Repair focused on measuring Infection, hernia repair

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age >18 y/o.
  • Elective, open ventral hernia repair in a retromuscular fashion, with or without TAR.
  • Clean, clean-contaminated, or contaminated wounds.

Exclusion Criteria:

  • Age <18 y/o.
  • Pregnancy.
  • Emergency hernia repair.
  • Laparoscopic, robotic, or hybrid approach.
  • Dirty wounds.
  • Use of biologic or absorbable synthetic mesh.
  • Onlay, intraperitoneal or preperitoneal mesh placement.

Sites / Locations

  • Prisma Health Upstate

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Saline Irrigation

Antibiotic Irrigation

Arm Description

Normal saline is to be placed into the dissected retromuscular space AFTER placement and fixation of mesh. This should fill the cavity completely to the level of the skin. Irrigant is to be left to stand for a total of three minutes and then evacuated. Additional irrigation with saline PRIOR to the randomization is permitted at the surgeons' discretion for hemostasis with no requirement for duration. Additional saline irrigation of the subcutaneous space after fascia closure should be performed prior to skin closure.

Antibiotic solution is prepared consisting of 240 mg gentamicin and 600 mg clindamycin in 500 ml saline to ensure proper concentration. This solution should be placed into the dissected retromuscular space AFTER placement and fixation of mesh. This should fill the cavity completely to the level of the skin. Irrigant is to be left to stand for a total of three minutes and then evacuated. Additional irrigation with saline PRIOR to the randomization is permitted at the surgeons' discretion for hemostasis with no requirement for duration. Additional antibiotic irrigation of the subcutaneous space after fascia closure should be performed prior to skin closure. This second irrigation is not timed.

Outcomes

Primary Outcome Measures

Surgical Site Infection
Number of participants with Surgical Site Infections

Secondary Outcome Measures

Incidence of SSI Requiring Intervention
Number of participants with SSI requiring reoperation or other procedural intervention at 30 days.

Full Information

First Posted
May 8, 2019
Last Updated
August 2, 2023
Sponsor
Prisma Health-Upstate
Collaborators
The Cleveland Clinic, Penn State University, Oregon Health and Science University
search

1. Study Identification

Unique Protocol Identification Number
NCT03945357
Brief Title
Reducing INfection at the Surgical SitE With Antibiotic Irrigation During Ventral Hernia Repair (RINSE Trial)
Acronym
RINSE
Official Title
Reducing INfection at the Surgical SitE With Antibiotic Irrigation During Ventral Hernia Repair (RINSE Trial)
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Completed
Study Start Date
May 15, 2019 (Actual)
Primary Completion Date
January 9, 2023 (Actual)
Study Completion Date
January 9, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Prisma Health-Upstate
Collaborators
The Cleveland Clinic, Penn State University, Oregon Health and Science University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
No

5. Study Description

Brief Summary
This is a study to determine if the incidence of infection at the Surgical SitE is impacted if with Antibiotic Irrigation is used during Ventral Hernia Repair (RINSE Trial)
Detailed Description
Surgical site infection (SSI) is common after open ventral hernia repair. Numerous factors contribute, including patient comorbidities, operative technique, and degree of contamination of the case. SSI often requires prolonged hospital length of stay (LOS), readmission, or other procedural intervention. One potential intervention to reduce SSI is the use of antibiotic irrigation, which has been shown to reduce SSI in colorectal surgery in a recent randomized control trial. We retrospectively evaluated our use of dual antibiotic irrigation at the time of mesh placement during open ventral hernia repair (OVHR), demonstrating a significant reduction in SSI (16.5 vs 5.4%) using a combination of gentamicin and clindamycin irrigation when compared to saline alone. We plan to complete a registry-based, randomized clinical trial (RCT) through the Americas Hernia Society Quality Collaborative (AHSQC) to further assess the impact of dual antibiotic irrigation on SSI after OVHR with mesh. This will include patients undergoing open retromuscular (RM) repair with or without transversus abdominis myofascial advancement flap (TAR) with placement of permanent synthetic mesh (mid-weight, large-pore polypropylene). Power analysis based on only this subset of patients from our initial study indicates a total of 210 patients are needed to demonstrate a significant reduction in SSI using antibiotic irrigation vs saline irrigation alone.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ventral Hernia Repair
Keywords
Infection, hernia repair

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Model Description
The study design would be a registry-based RCT through the AHSQC to evaluate the effect of dual antibiotic irrigation at the time of mesh placement during open RM +/-TAR OVHR.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
250 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Saline Irrigation
Arm Type
Active Comparator
Arm Description
Normal saline is to be placed into the dissected retromuscular space AFTER placement and fixation of mesh. This should fill the cavity completely to the level of the skin. Irrigant is to be left to stand for a total of three minutes and then evacuated. Additional irrigation with saline PRIOR to the randomization is permitted at the surgeons' discretion for hemostasis with no requirement for duration. Additional saline irrigation of the subcutaneous space after fascia closure should be performed prior to skin closure.
Arm Title
Antibiotic Irrigation
Arm Type
Active Comparator
Arm Description
Antibiotic solution is prepared consisting of 240 mg gentamicin and 600 mg clindamycin in 500 ml saline to ensure proper concentration. This solution should be placed into the dissected retromuscular space AFTER placement and fixation of mesh. This should fill the cavity completely to the level of the skin. Irrigant is to be left to stand for a total of three minutes and then evacuated. Additional irrigation with saline PRIOR to the randomization is permitted at the surgeons' discretion for hemostasis with no requirement for duration. Additional antibiotic irrigation of the subcutaneous space after fascia closure should be performed prior to skin closure. This second irrigation is not timed.
Intervention Type
Drug
Intervention Name(s)
Gemcitabine/ clindamycin
Intervention Description
Comparison of saline solution rinse vs antibiotic rinse
Intervention Type
Drug
Intervention Name(s)
Normal saline
Intervention Description
Comparison of saline solution rinse vs antibiotic rinse
Primary Outcome Measure Information:
Title
Surgical Site Infection
Description
Number of participants with Surgical Site Infections
Time Frame
30 days
Secondary Outcome Measure Information:
Title
Incidence of SSI Requiring Intervention
Description
Number of participants with SSI requiring reoperation or other procedural intervention at 30 days.
Time Frame
30 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age >18 y/o. Elective, open ventral hernia repair in a retromuscular fashion, with or without TAR. Clean, clean-contaminated, or contaminated wounds. Exclusion Criteria: Age <18 y/o. Pregnancy. Emergency hernia repair. Laparoscopic, robotic, or hybrid approach. Dirty wounds. Use of biologic or absorbable synthetic mesh. Onlay, intraperitoneal or preperitoneal mesh placement.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jeremy Warren, MD
Organizational Affiliation
Prisma Health-Upstate
Official's Role
Principal Investigator
Facility Information:
Facility Name
Prisma Health Upstate
City
Greenville
State/Province
South Carolina
ZIP/Postal Code
29615
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
There will be no patient information shared

Learn more about this trial

Reducing INfection at the Surgical SitE With Antibiotic Irrigation During Ventral Hernia Repair (RINSE Trial)

We'll reach out to this number within 24 hrs